This masterclass module has three components:
Registration for the masterclass workshop includes:
Registration confirmation: Please note that places are strictly limited, and registration is subject to confirmation by BioMelbourne Network.
The module leaders for this masterclass are Dr Melissa Martinson, President, Technomics Research, LLV (USA) and Mr Noel Martinson, President, Acclaim Data Analytics, LLC (USA).
This workshop will provide attendees with an in-depth look at the key considerations for using health economics analysis and real-world evidence in developing an effective value proposition for your medical technology.
Topics for discussion will cover understanding value, cost savings versus cost-effectiveness, the pros and cons of different approaches to economic analysis and making effective use of real-world data to enhance a company’s value proposition.
Melissa Martinson is a health services researcher and biostatistician. Her commercial experience includes 20 years of clinical trials, health economics and outcomes studies in both medical device and pharmaceutical companies.
Dr Martinson assists clients by evaluating the economics of their medical products and services. She has used economic analyses to show the trade-offs between the up-front costs of implantable devices and device therapies administered in-hospital, and savings achieved during the post-implant or post-treatment period. She has evaluated the impact of the initial use of second-tier pharmaceuticals on subsequent hospitalisation rates, and she has demonstrated the improved outcomes associated with the use of disease-management programs in managed care. Her economic analyses have helped payers understand the economic benefit of covering therapies in which the costs are all up-front, or in preventative measures, in which cases downstream costs to payers are averted. Dr Martinson frequently uses economic models in her analyses so that data from clinical trials, healthcare claims databases, and the literature can be combined. This enables her to complete economic analyses for clients quickly and inexpensively compared to economic analyses using primary data from outcomes studies.
Dr Martinson holds a BA in biology from Swarthmore College (in suburban Philadelphia), and both an MS in statistics and a PhD in health services research from the University of Minnesota. She holds an Adjunct Professorship at the University of Minnesota in the School of Public Health, where she teaches graduate-level economic modeling.
Noel Martinson has over 21 years of experience as a software developer and for the past eight years has specialised in applied analysis of large medical claims databases. He has in-depth knowledge of both Medicare and US commercial insurers’ medical claims databases as well as other sources of real-world evidence.
He uses his knowledge of these various data sets to help medical technology companies use real-world evidence to understand key trends in disease prevalence, incidence and progression; associated treatment, treatment volumes and complications; locations of treatment activity; cost structures of treatments; longitudinal analysis of care paths, costs and complications.
Mr Martinson holds a BS in mathematics from the University of Minnesota’s Institute of Technology.
Date: Wednesday 31 July 2019
Time: 8:45 am Registrations; 9:00 am–5:00 pm workshop, including networking lunch
Venue: Sofitel Melbourne on Collins, Level 35, 25 Collins St, Melbourne
Cost: $550 (incl. GST) for your first Healthcare Reimbursement module, then $440 (incl. GST) for each subsequent module.
Cancellation policy: A full refund is given up to 14 days prior to the event. No refunds within 14 days of the event.
To be eligible for consideration of the Go-to-Market in the USA travel awards, participants MUST register for and attend a minimum of two masterclass workshops throughout the program.
If you would like to be considered for the in-market component of the program please apply online no later than Wednesday 17 July. All applications will be considered to receive a travel award up to the value of AUD$3,000.
The Healthtech Reimbursement program is supported by